Harrow Health Inc is trading 5.2% up today at $40.40, extending a strong multi-day rebound from early June lows.
- The move follows the company's recent reaffirmation of its 2026 revenue guidance, which is projected to be between $350 million and $365 million.
- Investor sentiment appears to be recovering behind ongoing bullish analyst targets, helping the stock bounce back from a weak Q1 earnings report earlier this year.